In recent trading, shares of Reata Pharmaceuticals Inc (Symbol: RETA) have crossed above the average analyst 12-month target price of $119.18, changing hands for $167.19/share. When a stock reaches ...
Reata Pharmaceuticals (NASDAQ:RETA) stock is soaring higher on Friday as investors react to an acquisition deal with Biogen (NASDAQ:BIIB). That deal has Biogen offering to buy shares of RETA stock for ...
Singer RETA has ended her contract with rapper San E's agency following a home break-in incident. Reports claim an employee entered RETA's residence without permission while she was abroad, allegedly ...
Reata Pharmaceuticals, Inc. (NASDAQ:RETA) shareholders should be happy to see the share price up 26% in the last month. But that hardly compensates for the shocking decline over the last twelve months ...
Erin* has been using weight loss jabs for over six months. Desperate to lose 20kg, the 33-year-old first turned to Mounjaro at the end of last year. However, although it helped her shed the pounds, it ...
On a sharply down day at the tail end of the week, Reata Pharmaceuticals (NASDAQ:RETA) provided a dramatic counterpoint. While the benchmark S&P 500 index slipped near 2% down, RETA stock gained over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results